{"id":"W2141100300","doi":"10.3816/ccc.2010.n.043","title":"Phase I Trial of Oxaliplatin, Infusional 5-Fluorouracil, and Leucovorin (FOLFOX4) With Erlotinib and Bevacizumab in Colorectal Cancer","year":2010,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Medicine; Bevacizumab; Erlotinib; Oxaliplatin; Internal medicine; Colorectal cancer; FOLFOX; Rash; Mucositis; Gastroenterology; Neutropenia; Fluorouracil; Oncology; Chemotherapy; Cancer; Epidermal growth factor receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005179662,0.0003761064,0.001182289,0.0001337428,0.0001319227,0.0000257925,0.00009860571,0.0003010655,0.0003781565],"category_scores_gemma":[0.0004342997,0.0002707422,0.0001427047,0.0003501526,0.0009173826,0.000134922,0.000167214,0.0008270625,0.000001883902],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001222221,"about_ca_system_score_gemma":0.0007029042,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001357673,"about_ca_topic_score_gemma":0.01804386,"domain_scores_codex":[0.9974046,0.00009421674,0.0009272012,0.000710134,0.0004369223,0.0004268801],"domain_scores_gemma":[0.9982049,0.0007287743,0.0003239755,0.0001681411,0.0002529848,0.0003211629],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.3111317,0.002835366,0.5368491,0.0001542973,0.0004943867,0.0001090305,0.0007540837,0.000002600692,0.008698585,0.0001620788,0.0003355961,0.1384732],"study_design_scores_gemma":[0.2226547,0.02753811,0.7404097,0.0003170229,0.0005078068,0.00007968866,0.000234542,0.0002837536,0.004692699,0.0001182899,0.002665682,0.0004979849],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.993576,0.0015174,0.000001164501,0.0009837004,0.0008709239,0.001658058,0.0001685436,0.00004104291,0.001183141],"genre_scores_gemma":[0.9960998,0.001961626,0.0002996835,0.0001858939,0.0005599911,0.0006857332,0.0000188388,0.000038559,0.0001498712],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2035606,"threshold_uncertainty_score":0.9999745,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04145720672408924,"score_gpt":0.4011696703099102,"score_spread":0.3597124635858209,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}